Review article · 2023 · Open access
B Cell–Directed Therapy in Autoimmunity
Annual Review of Immunology, 42(1), 103–126 · Published 27 November 2023 · DOI 10.1146/annurev-immunol-083122-044829
In brief
“B Cell–Directed Therapy in Autoimmunity” is a 2023 review article by Ilana Y. Abeles and 5 co-authors, published in Annual Review of Immunology. OpenAlex counts 113 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at Annual Review of Immunology.
- Citations
- 113
- Most cited in
- 2026 (68)
- Field-weighted impact
- 2.62
- References
- 140
- Authors
- 6
Abstract
Autoimmune diseases with B cell-directed therapeutics approved by the US Food and Drug Administration are surprisingly diverse in clinical manifestations and pathophysiology. In this review, we focus on recent clinical and mechanistic insights into the efficacy of B cell depletion in these diverse autoimmune disorders, the rapidly expanding armamentarium of approved agents, and future approaches. The pathogenic roles for B cells include direct functions such as production of autoantibodies and proinflammatory cytokines and indirect functions via antigen presentation to T cells. The efficacy of B cell-depleting strategies varies across diseases and likely reflects the complexity of disease pathogenesis and relative contribution of B cell roles. Additionally, B cell-depleting therapies do not equally target all B cell subsets in all patients, and this likely explains some of the variability in responses. Recent reports of B cell depletion with novel chimeric antigen receptor (CAR) T cell approaches in an expanding number of autoimmune diseases highlight the potential role of B cell depletion in resetting immune tolerance. The relative importance of eliminating autoreactive B cells and plasma cells and approaches to doing so will also be discussed.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Abeles, I. Y., Palma, C., Meednu, N., Payne, A. S., Looney, R. J., & Anolik, J. H. (2023). B Cell–Directed Therapy in Autoimmunity. Annual Review of Immunology, 42(1), 103–126. https://doi.org/10.1146/annurev-immunol-083122-044829
MLA 9
Abeles, Ilana Y., et al. “B Cell–Directed Therapy in Autoimmunity.” Annual Review of Immunology, vol. 42, no. 1, 2023, pp. 103–126. https://doi.org/10.1146/annurev-immunol-083122-044829.
Chicago
Abeles, Ilana Y., Christopher Palma, Nida Meednu, Aimee S. Payne, Richard John Looney, and Jennifer H. Anolik. 2023. “B Cell–Directed Therapy in Autoimmunity.” Annual Review of Immunology 42 (1): 103–126. https://doi.org/10.1146/annurev-immunol-083122-044829.
Harvard
Abeles, I. Y. et al. (2023) ‘B Cell–Directed Therapy in Autoimmunity’, Annual Review of Immunology, 42(1), pp. 103–126. doi:10.1146/annurev-immunol-083122-044829.
IEEE
I. Y. Abeles, C. Palma, N. Meednu, A. S. Payne, R. J. Looney, and J. H. Anolik, “B Cell–Directed Therapy in Autoimmunity,” Annual Review of Immunology, vol. 42, no. 1, pp. 103–126, 2023, doi: 10.1146/annurev-immunol-083122-044829.
BibTeX
@article{abeles2023cell,
title = {{B Cell–Directed Therapy in Autoimmunity}},
author = {Abeles, Ilana Y. and Palma, Christopher and Meednu, Nida and Payne, Aimee S. and Looney, Richard John and Anolik, Jennifer H.},
journal = {Annual Review of Immunology},
year = {2023},
volume = {42},
number = {1},
pages = {103--126},
doi = {10.1146/annurev-immunol-083122-044829},
url = {https://doi.org/10.1146/annurev-immunol-083122-044829}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 1 | |
| 2024 | 6 | |
| 2025 | 38 | |
| 2026 | 68 |
Its field-weighted citation impact is 2.62: it has been cited 2.62 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- B-cell depletion
- B cell-directed therapy
- autoimmune disease
- autoantibodies
- inflammatory cytokines
- B cell subsets
- chimeric antigen receptor T cells
- immune tolerance
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Abeles, I. Y., Palma, C., Meednu, N., Payne, A. S., Looney, R. J., & Anolik, J. H. (2023). B Cell–Directed Therapy in Autoimmunity. Annual Review of Immunology, 42(1), 103–126. https://doi.org/10.1146/annurev-immunol-083122-044829
How many times has this paper been cited?
113 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Annual Review of Immunology: sign in and open the PDF from this page.
Who wrote this paper?
Ilana Y. Abeles, Christopher Palma, Nida Meednu, Aimee S. Payne, Richard John Looney, Jennifer H. Anolik.
What is the DOI of this paper?
10.1146/annurev-immunol-083122-044829, permanently at https://doi.org/10.1146/annurev-immunol-083122-044829. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.